Avamed Synergy

avamedsynergy.es ↗ ·Alicante ·Seed

Avamed Synergy is a Spanish deep-tech medtech company building digital surgery and predictive oncology software, led by its Fluxus platform, which uses AI, big data and predictive modelling on medical imaging to forecast individual tumour evolution and simulate complex surgical procedures. Founded in 2012 and based at the Distrito Digital hub in Alicante (with Murcian origins), it holds Spain's Innovative SME seal and runs clinical research collaborations with IMIB Murcia, IBIMA Málaga, SACYL Innova, ISABIAL and INCLIVA, having supported 80+ complex surgical cases. It closed a first ~€800K round in early 2024 (including ENISA) and opened a ~€5M round in 2025 ahead of CE marking and market entry targeted for 2026.

Founded

2012

Founders

Total funds raised

€500K+

SectorsHealthtech, Medtech, Digital Surgery, Oncology, AI & Data, Deeptech, Medical Imaging Start-up MapHealthtech & Bio › Clinical software & health data

Suggest a correction

Founders

Lucas Antonio Diez Martínez

CEO and Founder

Global models 5

Lunit

South Korea · www.lunit.io ↗

Sells AI software that reads medical images to support cancer diagnosis and predict treatment response, licensed to hospitals and imaging providers.

$300MComparable

Proprio

United States · www.propriovision.com ↗

Sells a digital surgery platform that uses AI and 3D imaging to plan and guide complex operations, sold to hospitals and surgeons.

$80MComparable

Axial3D

United Kingdom · axial3d.com ↗

Turns patient scans into AI-built 3D models that surgeons use to plan complex procedures, licensed to hospitals and medtech firms.

$40MComparable

Theator

Israel · theator.io ↗

Sells hospitals an AI surgical-intelligence platform that analyses surgery data to improve how operations are planned and performed.

$40MComparable

SimBioSys

United States · www.simbiosys.com ↗

Its TumorSight software builds patient-specific 3D tumour models from MRI to predict tumour behaviour and plan cancer surgery, the closest match to Fluxus.

$30MComparable

In the same niche 53 others

See all in the Start-ups Map →

+47 more →

Notes: Most funded first

Investors 2

Existing investor partners (undisclosed)

Seed 2025 HQ unknown

Undisclosed private investors

Seed 2024 HQ unknown

Funding rounds 2

·1 not counted

Date	Round	Amount	Lead
2025-04-10	Seed	—	Lead not disclosed +1 more
2024-01-08	Seed (estimated)	€500K	Lead not disclosed +1 more

Not counted (1)

Not counted in totals

2024-01-08 Public Loan €300K ENISA

News 9

Open as list →

Published	Article
2026-06-06	Ivace+i financia una herramienta con IA para anticipar el riesgo de rotura de aneurismas ↗ Valencia Plaza 2026-06-06
2025-11-28	AWARD-WINNERS - EUROPEAN AWARDS IN MEDICINE 2025 ↗ The European Awards (El Suplemento) 2025-11-28
2025-04-10	Avamed Synergy busca conseguir 5 M€ con una nueva ronda de inversión ↗ Murcia Diario 2025-04-10
2025-02-03	El Instituto Valenciano de Competitividad e Innovación (IVACE+i) concede a Avamed Synergy la aprobación y financiación de un nuevo proyecto de innovación ↗ Biotech Spain 2025-02-03
2024-11-29	Award-winners of the European Technology Awards 2024 ↗ The European Awards (El Suplemento) 2024-11-29
2024-11-04	Avamed Synergy present at the seventh edition of the Valencia Digital Summit ↗ MedicalExpo Trends 2024-11-04
2024-04-30	Conversation: Lucas Antonio Diez Martinez – Founder and Chief Executive Officer, Avamed Synergy, Spain ↗ Executive Forecast 2024-04-30
2024-01-08	Avamed Synergy alcanza los 800.000 euros en su primera ronda y avanza en su proyecto Fluxus ↗ Alicante Plaza 2024-01-08
2018-11-25	Lucas Antonio on Redefining Tumor Treatment with Fluxus ↗ Tech CEOs 2018-11-25